BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8088368)

  • 21. High affinity binding of cholecystokinin to small cell lung cancer cells.
    Yoder DG; Moody TW
    Peptides; 1987; 8(1):103-7. PubMed ID: 3033616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrin receptors on nonparietal cells isolated from canine fundic mucosa.
    Soll AH; Amirian DA; Thomas LP; Park J; Elashoff JD; Beaven MA; Yamada T
    Am J Physiol; 1984 Dec; 247(6 Pt 1):G715-23. PubMed ID: 6095679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe.
    Wennogle LP; Steel DJ; Petrack B
    Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G; Beinborn M; Sewing KF
    Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of antisera to cholecystokinin by use of different cholecystokinin labels.
    Jansen JB; Lamers CB
    J Immunol Methods; 1984 Jun; 71(1):1-8. PubMed ID: 6539353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
    Harper EA; Griffin EP; Shankley NP; Black JW
    Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes.
    Yuan DS; Wank SA; Gardner JD
    Biochim Biophys Acta; 1993 Feb; 1146(1):52-8. PubMed ID: 8443227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological and biochemical evidence for the simultaneous expression of CCKB/gastrin and CCKA receptors in the pig pancreas.
    Philippe C; Lhoste EF; Dufresne M; Moroder L; Corring T; Fourmy D
    Br J Pharmacol; 1997 Feb; 120(3):447-54. PubMed ID: 9031748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
    Galas MC; Bernad N; Martinez J
    Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Pandya PK; Huang SC; Talkad VD; Wank SA; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):117-26. PubMed ID: 7948036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
    Lucaites VL; Mendelsohn LG; Mason NR; Cohen ML
    J Pharmacol Exp Ther; 1991 Feb; 256(2):695-703. PubMed ID: 1704435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrin receptors on isolated canine parietal cells.
    Soll AH; Amirian DA; Thomas LP; Reedy TJ; Elashoff JD
    J Clin Invest; 1984 May; 73(5):1434-47. PubMed ID: 6325503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR; Woodruff GN
    Brain Res; 1990 Sep; 526(2):276-83. PubMed ID: 2257485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
    Harper EA; Shankley NP; Black JW
    Br J Pharmacol; 1999 Mar; 126(6):1504-12. PubMed ID: 10217546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of gastrin receptors on guinea pig pancreatic acini.
    Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.